The global CAR T-cell therapy market is witnessing rapid growth, driven by increasing incidence of cancer and positive regulatory policies. Leading players in the market are participating in innovation to enhance their product portfolio and meet the growing requirement for effective cancer treatments. Moreover, advancements in CAR T-cell therapy t